Market Cap (In CNY)
11.35 Billion
Revenue (In CNY)
2.76 Billion
Net Income (In CNY)
487.62 Million
Avg. Volume
5.3 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 19.2-31.5
- PE
- -
- EPS
- -
- Beta Value
- 0.685
- ISIN
- CNE100002102
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Zhongxiong Peng
- Employee Count
- -
- Website
- https://www.wondfo.com.cn
- Ipo Date
- 2015-06-30
- Details
- Guangzhou Wondfo Biotech Co.,Ltd, a biological company, engages in the research and development, production, and sale of point-of-care testing products, and rapid diagnosis and chronic disease management solutions. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious, fertility, and sexually transmitted diseases, as well as immunofluorescence devices to detect cardiovascular diseases, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and other diseases. It also provides blood gas, optical coagulation, and dry chemistry analyzers. The company was founded in 1992 and is headquartered in Guangzhou, China.
More Stocks
-
PIMO
-
DELPHIFXDelphi World Money Limited
DELPHIFX
-
010690HWASHIN CO.,Ltd
010690
-
FMCCH
-
OMNIPOTENTOmnipotent Industries Limited
OMNIPOTENT
-
7719
-
CGKEY
-
SHWGF